Ed Notargiacomo - Partner55 Cambridge ParkwaySuite 301 Cambridge, MA 02142 Phone: (617) 475-1960 ed@hbsslaw.com |
|
|
|
Edward Notargiacomo is a partner at Hagens Berman Sobol Shapiro where he has worked since 2002. He joined the firm’s Boston office to focus on complex consumer, commercial and antitrust litigation. Mr. Notargiacomo is involved in the Average Wholesale Price Litigation, including the 2006 trial of claims against AstraZeneca, Bristol Myers Squibb, Johnson & Johnson, and Schering-Plough. Mr. Notargiacomo was also involved in the Neurontin Promotions Litigation which recently resulted in a jury verdict of approximately $142 million against Pfizer. In addition, Mr. Notargiacomo is currently involved in antitrust litigation against GlaxoSmithKline involving the drugs Wellbutrin SR and Flonase. Mr. Notargiacomo also heads up the firm’s Smoke Alarms Litigation.
Mr. Notargiacomo’s extensive experience in complex cases also includes consumer class actions against predatory lenders and employment litigation against a major retail chain, as well as intense involvement in high-profile impact litigation against cigarette manufacturers, the firearms industry, and pharmaceutical manufacturers.
Before joining Hagens Berman Sobol Shapiro, Mr. Notargiacomo served as Special Assistant Attorney General for Massachusetts in its suit against the tobacco industry to recoup funds expended to treat smoking related illnesses. He also helped represent Rhode Island, New Hampshire and Maine in their suits against the tobacco industry. In another case, he represented the city of Boston in its suit against gun manufacturers and distributors in order to force them to take responsibility for violence perpetrated with firearms that negligently and illegally distributed in cities like Boston.
Mr. Notargiacomo received his bachelor’s degree from Brown University in 1989. He earned his juris doctor with honors from Boston University in 1994 where he served on the Boston University Public Interest Law Review. He is admitted to practice in Massachusetts and in the U.S. District Court for the District of Massachusetts. |
||